drugset / Trial / NCT02859129
Study to Evaluate the 2-Way Interaction Between Multiple Doses of Epanova™ and a Single Dose of Rosuvastatin (Crestor®)
RandomizedParallel-groupOpen-labelTreatment
Summary
This study is intended to evaluate the potential 2-way reciprocal interaction between multiple doses of Epanova™ and a single dose of rosuvastatin
Timeline
- Start
- 2013-09
- Primary completion
- 2013-11
- Completion
- 2013-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Epanova | Other / unclassified | 2 g | Oral |
| Subject | Epanova | Other / unclassified | 4 g | Oral |
| Subject | Rosuvastatin | Small molecule | 40 mg | Oral |
| Comparator | icosapent ethyl | Small molecule | 2 g | Oral |